With extensive experience in venture capital, the fund manager has successfully led numerous investments across technology and life sciences sectors. Active primarily in Europe and North America, they have completed over 50 deals, demonstrating a strong ability to identify and capitalize on emerging trends. Their operator-first approach focuses on early-stage investments, fostering growth through strategic support. Notable exits include significant returns from companies that have excelled in innovation-driven markets, showcasing an adeptness for navigating complex landscapes.